In addition, the new solution boasts the industry's leading phase
error performance using an advanced algorithm supporting G.
API intelligence over leading Phase
III pipeline drugs.
a contract formulation, development and manufacturing company of oral solid dosage pharmaceuticals, has a reputation as one of the leading Phase
I-III clinical trial materials manufacturers in the United States.
Simon Linford, executive chairman of Linford Group, said: "We are proud to be leading phase
one in the restoration of this magnificent example of 15th century architecture.
ADI), a global leader in high-performance semiconductors for signal-processing applications and leading provider of RF ICs (radio frequency integrated circuits), today announced the release of a PLL synthesizer that offers leading phase
Omnicare Clinical Research is a leading Phase
I to IV global contract research organization serving the biopharmaceutical and medical device industries.
Chiltern, the global contract research organization, announced today that it has acquired the business of Drug Development Solutions ('DDS'), a leading Phase
1 unit located at Ninewells Hospital and Medical School, Dundee, Scotland.
Other factors included results from TriQuint's Defense Advanced Research Projects Agency (DARPA) Wide Bandgap Semiconductor (WBGS) RF GaN program, in which TriQuint led Phase II and is leading Phase
As a leading Phase
I through IV CRO with locations in 31 countries, Omnicare Clinical Research manages trials for pharmaceutical, biotechnological, nutraceutical and medical device companies of all sizes and specialties.
These new devices are based on ADI's PLL/VCO synthesizer, mixer and modulator technologies, which offer the industry's leading phase
noise performance, power consumption and linearity for smaller form factor and higher density macro, micro, and picocell base stations.
Chapters 4, 5 and 6 provide a review of the leading phase
I, II and III clinical stage partnering deals since 2000, respectively.
Neville has had extensive training in experimental therapeutics for children with cancer, and is leading Phase
I research efforts to develop new agents for the treatment of pediatric cancer and supportive care for patients.